Dermatology
Latest News
FDA approves secukinumab in psoriasis patients age six and older
“This has changed the playing field for these children and their families completely.”
News
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
Patients who take methotrexate or rituximab seem to be especially vulnerable.
Conference Coverage
Psoriasis associated with an increased risk of COVID-19 in real-world study
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
News
Study aims to enhance understanding of ‘tremendously understudied’ prurigo nodularis
“If you encounter a patient with prurigo nodularis, it’s important to perform a screening for chronic kidney disease, diabetes, and liver disease...
News
Data about COVID-19-related skin manifestations in children continue to emerge
Of 50 hospitalized children infected with COVID-19, 18 (36%) fulfilled criteria for Multisystem Inflammatory Syndrome in Children.
News
Secukinumab brings high PASI 75 results in 6- to 17-year-olds with psoriasis
The week-24 PASI 75 rate was 95% in a phase 2 study.
Conference Coverage
What’s the future of telehealth? It’s ‘complicated’
“The problems are systemic, and they have to do with various factors: The portal, the equipment, Internet access, and inadequate or no health...
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
Conference Coverage
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
The rationale is to optimize the antibody response to the killed-adenovirus COVID-19 vaccine.
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...